Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Rep Pract Oncol Radiother ; 29(1): 90-96, 2024.
Article in English | MEDLINE | ID: mdl-39165603

ABSTRACT

Background: The current study aimed to determine the overall survival (OS) rates of patients diagnosed with pediatric gliomas in Brazil, accounting for the influence of age, treatment modalities, and tumor site, using a population-based national database. Materials and methods: Patients diagnosed with pediatric gliomas of central nervous system (CNS) from 1999-2020 were identified from The Fundação Oncocentro de São Paulo public database. The Kaplan-Meier and the log-rank test were used for survival analysis. Results: A total of 1296 patients were included. The most common histologic tumor types were glioblastomas (38.27%; n = 496), pilocytic astrocytoma (32.87%; n = 426), and astrocytoma grade II (20.76%; n = 269). A total of 379 (29.24%) had brainstem tumors. The mean follow-up was 135 months [95% confidence interval (CI) 128-142\. The 1-year, 3-year 5-year OS for pilocytic astrocytoma were 93.72%, 89.98%, and 88.97%; for grade II gliomas, 80.36%, 71.89%, and 68.60%; for grade III gliomas, 53.72%; 31.87%, and 28.33%; and for glioblastoma, 52.90%, 28.76%, 25.20%, respectively. Brainstem tumors had the worse OS compared to no brainstem tumors (p = 0.001). For high-grade glioma (grade III/IV), excluding brainstem tumors (n = 570), young patients had greater median OS (0 to 3 years:22 months; 4 to 18 years:13 months; p = 0.005). Regarding the treatment modalities, combined treatments were associated with higher median survival compared to less intensive therapy (surgery: 11 months; surgery and chemotherapy: 16 months; surgery, radiotherapy, and chemotherapy: 20 months; p = 0.005). Conclusion: In our cohort, low-grade gliomas had favorable prognoses and outcomes. Patients diagnosed with glioblastomas and brainstem gliomas had the worst OS. For high-grade gliomas, undergoing treatment de-intensification in the Brazilian pediatric population is associated with worse survival.

2.
PLoS One ; 19(6): e0304682, 2024.
Article in English | MEDLINE | ID: mdl-38900739

ABSTRACT

Central nervous system (CNS) malignant neoplasms may lead to venous thromboembolism (VTE) and bleeding, which result in rehospitalization, morbidity and mortality. We aimed to assess the incidence of VTE and bleeding in this population. METHODS: This systematic review and meta-analysis (PROSPERO CRD42023423949) were based on a standardized search of PubMed, Virtual Health Library and Cochrane (n = 1653) in July 2023. After duplicate removal, data screening and collection were conducted by independent reviewers. The combined rates and 95% confidence intervals for the incidence of VTE and bleeding were calculated using the random effects model with double arcsine transformation. Subgroup analyses were performed based on sex, age, income, and type of tumor. Heterogeneity was calculated using Cochran's Q test and I2 statistics. Egger's test and funnel graphs were used to assess publication bias. RESULTS: Only 36 studies were included, mainly retrospective cohorts (n = 30, 83.3%) from North America (n = 20). Most studies included were published in high-income countries. The sample size of studies varied between 34 and 21,384 adult patients, mostly based on gliomas (n = 30,045). For overall malignant primary CNS neoplasm, the pooled incidence was 13.68% (95%CI 9.79; 18.79) and 11.60% (95%CI 6.16; 18.41) for VTE and bleeding, respectively. The subgroup with elderly people aged 60 or over had the highest incidence of VTE (32.27% - 95%CI 14.40;53.31). The studies presented few biases, being mostly high quality. Despite some variability among the studies, we observed consistent results by performing sensitivity analysis, which highlight the robustness of our findings. CONCLUSIONS: Our study showed variability in the pooled incidence for both overall events and subgroup analyses. It was highlighted that individuals over 60 years old or diagnosed with GBM had a higher pooled incidence of VTE among those with overall CNS malignancies. It is important to note that the results of this meta-analysis refer mainly to studies carried out in high-income countries. This highlights the need for additional research in Latin America, and low- and middle-income countries.


Subject(s)
Central Nervous System Neoplasms , Hemorrhage , Venous Thromboembolism , Humans , Venous Thromboembolism/epidemiology , Venous Thromboembolism/etiology , Central Nervous System Neoplasms/epidemiology , Central Nervous System Neoplasms/complications , Incidence , Hemorrhage/epidemiology , Male , Female
3.
Neurol Sci ; 45(7): 3051-3059, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38353849

ABSTRACT

Monitoring intracranial pressure (ICP) is pivotal in the management of severe traumatic brain injury (TBI), but secondary brain injuries can arise despite normal ICP levels. Cerebral tissue oxygenation monitoring (PbtO2) may detect neuronal tissue infarction thresholds, enhancing neuroprotection. We performed a systematic review and meta-analysis to evaluate the effects of combined cerebral tissue oxygenation (PbtO2) and ICP compared to isolated ICP monitoring in patients with TBI. PubMed, Embase, Cochrane, and Web of Sciences databases were searched for trials published up to June 2023. A total of 16 studies comprising 37,820 patients were included. ICP monitoring was universal, with additional placement of PbtO2 in 2222 individuals (5.8%). The meta-analysis revealed a reduction in mortality (OR 0.57, 95% CI 0.37-0.89, p = 0.01), a greater likelihood of favorable outcomes (OR 2.28, 95% CI 1.66-3.14, p < 0.01), and a lower chance of poor outcomes (OR 0.51, 95% CI 0.34-0.79, p < 0.01) at 6 months for the PbtO2 plus ICP group. However, these patients experienced a longer length of hospital stay (MD 2.35, 95% CI 0.50-4.20, p = 0.01). No significant difference was found in hospital mortality rates (OR 0.81, 95% CI 0.61-1.08, p = 0.16) or intensive care unit length of stay (MD 2.46, 95% CI - 0.11-5.04, p = 0.06). The integration of PbtO2 to ICP monitoring improved mortality outcomes and functional recovery at 6 months in patients with TBI. PROSPERO (International Prospective Register of Systematic Reviews) CRD42022383937; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=383937.


Subject(s)
Brain Injuries, Traumatic , Intracranial Pressure , Humans , Brain Injuries, Traumatic/therapy , Brain Injuries, Traumatic/mortality , Brain Injuries, Traumatic/physiopathology , Intracranial Pressure/physiology , Neurophysiological Monitoring/methods , Oxygen/metabolism , Oxygen/blood , Brain/metabolism , Brain/physiopathology , Monitoring, Physiologic/methods
4.
Neurosurg Rev ; 47(1): 47, 2024 Jan 15.
Article in English | MEDLINE | ID: mdl-38221545

ABSTRACT

BACKGROUND AND OBJECTIVES: High-grade gliomas (HGGs) are aggressive tumors of the central nervous system that cause significant morbidity and mortality. Despite advances in surgery and radiation therapy (RT), HGG still has a high incidence of recurrence and treatment failure. Intraoperative radiotherapy (IORT) has emerged as a promising therapeutic approach to achieve local tumor control while sparing normal brain tissue from radiation-induced damage. METHODS: A systematic review and meta-analysis were conducted following PRISMA guidelines to evaluate the use of IORT for HGG. Eligible studies were included based on specific criteria, and data were independently extracted. Outcomes of interest included complications, IORT failure, survival rates at 12 and 24 months, and mortality. RESULTS: Sixteen studies comprising 436 patients were included. The overall complication rate after IORT was 17%, with significant heterogeneity observed. The IORT failure rate was 77%, while the survival rates at 12 and 24 months were 74% and 24%, respectively. The mortality rate was 62%. CONCLUSION: This meta-analysis suggests that IORT may be a promising adjuvant treatment for selected patients with HGG. Despite the high rate of complications and treatment failures, the survival outcomes were comparable or even superior to conventional methods. However, the limitations of the study, such as the lack of a control group and small sample sizes, warrant further investigation through prospective randomized controlled trials to better understand the specific patient populations that may benefit most from IORT. However, the limitations of the study, such as the lack of a control group and small sample sizes, warrant further investigation. Notably, the ongoing RP3 trial (NCT02685605) is currently underway, with the aim of providing a more comprehensive understanding of IORT. Moreover, future research should focus on managing complications associated with IORT to improve its safety and efficacy in treating HGG.


Subject(s)
Brain Neoplasms , Glioma , Humans , Brain Neoplasms/radiotherapy , Brain Neoplasms/surgery , Brain Neoplasms/drug therapy , Prospective Studies , Glioma/radiotherapy , Glioma/surgery , Neoplasm Recurrence, Local , Radiotherapy/adverse effects
5.
Arq. neuropsiquiatr ; 80(9): 922-928, Sept. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1420250

ABSTRACT

Abstract Background The neutrophil-to-lymphocyte (NLR), monocyte-to-lymphocyte (MLR), platelet-to-lymphocyte ratio (PLR), and red blood cell distribution width (RDW) have been previously studied as predictors of survival in different malignancies. Objective The aim of this study was to evaluate the predictive value of these hematologic inflammatory biomarkers for patients with brain metastases (BM). Methods We reviewed a consecutive cohort of patients at Instituto do Cancer do Estado de São Paulo (ICESP-FMUSP) from 2011 to 2016 with ≥ 1 BM treated primarily by surgical resection. The primary outcome was 1-year survival. We optimized the NLR, MLR, PLR, and RDW cutoff values, preserving robustness and avoiding overestimation of effect size. Results A total of 200 patients (mean age 56.1 years; 55.0% female) met inclusion criteria. Gross-total resection was achieved in 89.0%. The median (quartiles) preoperative and postoperative KPS scores were 60 (50-80) and 80 (60-90), respectively. Preoperative NLR was significantly associated with survival (HR 2.66, 95% CI: 1.17-6.01, p = 0.019). A NLR cutoff value of 3.83 displayed the most significant survival curve split. Conclusions Preoperative NLR is an independent predictor of survival in newly diagnosed BM. We propose a cutoff value of 3.83 for preoperative NLR testing may be clinically useful as predictor of poor survival in this population. The wide accessibility of the NLR favors its inclusion in clinical decision-making processes for BM management.


Resumo Antecedentes Os neutrófilos para linfócitos (NLR), monócitos para linfócitos (MLR), proporção de plaquetas para linfócitos (PLR) e largura de distribuição de glóbulos vermelhos (RDW) foram previamente estudados como preditores de sobrevivência em diferentes malignidades. Objetivo O objetivo deste estudo foi avaliar o valor preditivo desses biomarcadores inflamatórios hematológicos para pacientes com metástases cerebrais (MB). Métodos Nós revisamos uma coorte consecutiva de pacientes no Instituto do Câncer do Estado de São Paulo (ICESP-FMUSP) de 2011 a 2016 com ≥ 1 MB tratados principalmente por ressecção cirúrgica. O desfecho primário foi a sobrevida em 1 ano. Otimizamos os valores de corte de NLR, MLR, PLR e RDW, preservando a robustez e evitando superestimação do tamanho do efeito. Resultados Um total de 200 pacientes (idade média de 56,1 anos; 55,0% mulheres) preencheram os critérios de inclusão. A ressecção grosseira total foi obtida em 89,0%. A mediana (quartis) dos escores KPS pré-operatório e pós-operatório foram 60 (50-80) e 80 (60-90), respectivamente. O NLR pré-operatório foi significativamente associado à sobrevida (HR 2,66, IC 95%: 1,17-6,01, p = 0,019). Um valor de corte de NLR de 3,83 exibiu a divisão da curva de sobrevivência mais significativa. Conclusões O NLR pré-operatório é um preditor independente de sobrevida em MBs recém-diagnosticados. Propomos que um valor de corte de 3,83 para o teste de NLR pré-operatório pode ser clinicamente útil como preditor de baixa sobrevida nesta população. A ampla acessibilidade do NLR favorece sua inclusão nos processos de tomada de decisão clínica para o gerenciamento de BM.

6.
Rev. chil. neurocir ; 41(1): 93-96, jul. 2015. ilus, tab
Article in English | LILACS | ID: biblio-836050

ABSTRACT

Occipital condyle fractures (OCF) had been difficult to diagnose, but the widespread use of computed tomography (CT) as a diagnostic tool in patients with significant cranio-cervical injury has led to increased recognition of this injury. The incidence of OCF in severely injured blunt trauma patients is estimated at 0.1 - 4.4 percent and as high as 16 percent overall when less severely injured patients are included. OCFs are important because they may be associated with instability of the occipito-atlanto-axial joint complex and there is wide variability in the clinical presentation of individuals with an OCF. This cranio-cervical injury may result in increased morbidity associated with long-term cranio-cervical pain and reduced neck mobility. Patient outcomes tend to reflect the severity of additional injuries rather than independent OCF pathology. We described three OCF cases with severe traumatic brain injury, treated without surgery with favorable outcome and we performed a literature review.


Subject(s)
Humans , Male , Adult , Middle Aged , Skull Fractures , Skull Fractures/therapy , Occipital Bone , Severity of Illness Index , Tomography, X-Ray Computed
7.
Arq. bras. neurocir ; 33(2)jun. 2014. ilus, tab
Article in Portuguese | LILACS | ID: lil-721672

ABSTRACT

A embolia gordurosa é constituída pela presença de glóbulos de gordura dentro da microcirculação periférica e pulmonar, com ou sem quadro clínico. Há uma fase precoce, representada por uma obstrução mecânica, e uma fase tardia, representada por um fenômeno inflamatório, que se inicia aproximadamente 48 a 72 horas após a obstrução mecânica. O diagnóstico clínico da síndrome de embolia gordurosa pode ser auxiliado pelos critérios de Gurd-Wilson e deve ser suspeitado em doentes com traumatismo e fraturas de ossos longos e deterioração neurológica de forma inexplicada. É necessário no mínimo um critério maior (insuficiência respiratória, sinais neurológicos não relacionados ao traumatismo craniano e manifestações dermatológicas) e quatro menores ou dois maiores. Exames complementares são geralmente inespecíficos. A tomografia de crânio pode estar normal. A ressonância magnética de encéfalo pode mostrar áreas puntiformes que costumam desaparecer em 20 dias, sugerindo que a lesão pode ser predominantemente inflamatória, e não necrótico-isquêmica. Um tratamento específico para a síndrome de embolia gordurosa não existe. Ele consiste no suporte cardiopulmonar e neurológico, além de prevenção e diagnóstico precoce, auxiliando nos cuidados com o doente.


Fat embolism is constituted by the presence of fat globules in the peripheral microcirculation and lung with or without symptoms. There is an early stage, represented by a mechanical obstruction, and a late phase, represented by an inflammatory process, which begins approximately 48-72 hours after the mechanical obstruction. The clinical diagnosis of the syndrome of fat embolism can be aided by the criteria of Gurd-Wilson, and must be suspected in patients with trauma and long bone fractures and unexplained neurological deterioration. It is necessary at least one major criteria (respiratory failure, neurological signs unrelated to head trauma and skin lesions) and four small or two larger ones. Additional tests are usually nonspecific. CT scan may be normal. MRI may show punctate areas that usually disappear in 20 days, suggesting that the inflammatory lesion may be predominantly necrotic and non-ischemic. Specific treatment for fat embolism syndrome does not exist. It is the neurological and cardiopulmonary support, and prevention and early diagnosis, assisting in patient care.


Subject(s)
Humans , Embolism, Fat/diagnosis , Embolism, Fat/therapy , Brain Injuries, Traumatic
8.
Arq. bras. neurocir ; 33(2)jun. 2014. ilus
Article in Portuguese | LILACS | ID: lil-721678

ABSTRACT

Cisternal spinal accessory schwannoma are still a rare condition without neurofibromatosis with only 32 cases reported so far. We describe a cisternal accessory schwannoma presented in a 36-year-old woman with posterior cervical pain and cervical mieolopaty, defined by grade IV tetraparesia. A suboccipital craniectomy with C1 posterior arch resection was performed. During microsurgical dissection together with electrophysiological monitoring and nerve stimulation tumor was identified as having the spinal accessory root as its origins. Carefully intraneural dissection was then performed with complete lesion removal, histopatological examination confirmed the hypothesis of schwannoma. The patient was free from pain and improved her neurological status with no accessory nerve palsy. Complete surgical resection is indicated for such lesions and can be achieved with good outcome.


O schwannoma do ramo espinhal do nervo acessório em sua porção cisternal, quando não associado à neurofibromatose, é uma condição rara, com apenas 32 relatos de caso na literatura. O diagnóstico diferencial da lesão deve ser atentado, principalmente no que diz respeito à preservação da função motora do nervo acessório. Este é um relato de caso de uma paciente do sexo feminino de 36 anos com queixa de cervicalgia associada à mielopatia cervical compressiva secundária à lesão expansiva intradural, extramedular, estendendo-se do forame magno até a porção superior da lâmina de C2. A paciente foi submetida a uma craniectomia de fossa posterior e ressecção do arco posterior de C1. Durante exploração cirúrgica, auxiliada por monitoração eletrofisiológica e estimulação neural, foi identificado que a lesão tinha origem no ramo espinhal do nervo acessório direito. Foi então ressecada de forma completa com preservação dos fascículos íntegros do nervo de origem. O exame anatomopatológico confirmou a hipótese de schwannoma. A paciente evoluiu sem dor e com melhora do quadro neurológico, sendo preservada a função do nervo acessório. O schwannoma do ramo espinhal do nervo acessório é uma condição rara. A ressecção cirúrgica total é o tratamento de escolha para esses pacientes e pode ser alcançada sem lesões neurológicas significativas secundárias ao ato cirúrgico.


Subject(s)
Humans , Female , Adult , Accessory Nerve Diseases , Microsurgery , Neurilemmoma
10.
Arq. bras. neurocir ; 32(2)jun. 2013.
Article in Portuguese | LILACS | ID: lil-681383

ABSTRACT

O traumatismo cranioencefálico (TCE) corresponde a uma das principais causas de morte em adultos jovens. Alguns pacientes com TCE podem ser vítimas de várias alterações hormonais decorrentes do trauma. Algumas são facilmente reconhecíveis, como diabetes insipidus, enquanto outras podem passar despercebidas inicialmente, como a deficiência do hormônio do crescimento (GH). As alterações neuroendócrinas após a ocorrência de trauma podem cursar com deficiências da hipófise anterior, da posterior ou de ambas, acometer apenas um eixo hormonal ou vários e, ainda, ser transitórias ou permanentes. A grande maioria dos pacientes que apresentam disfunção neuroendócrina foi vítima de traumas considerados moderados ou graves pela escala de Glasgow. No entanto, a maioria dos estudos não evidenciou relação entre a gravidade da lesão e a ocorrência de alteração hipofisária pósTCE. As deficiências hipofisárias devem ser tratadas precocemente, uma vez que déficits hormonais hipofisários dificultam a recuperação dos pacientes traumatizados, constituindo-se em fator de pior prognóstico. Apesar da frequência com que ocorrem os TCE, existem poucos estudos a respeito das complicações neuroendócrinas decorrentes...


Traumatic brain injury (TBI) is one of the main causes of death in young adults. Some cases of TBI could lead to the development of easily recognizable diabetes insipidus. In other cases it can lead to alterations in the endocrine axis that are more difficult to notice at the beginning and that can occur together with other hormone deficiencies. The majority of patients with neuroendrocrine dysfunction were TBI victims with a Glasgow Coma Scale scores of 3-13 (moderate and severe trauma). However, previous studies did not show correlationships between the severity of injury and pan-hypopituitarism after TBI. The pituitary disorders have to be treated as soon as possible because it makes the recovery of TBI patients more difficult and lead to a worse prognosis. Despite the number of studies about TBI, actually there are only a few studies concerning the secondary neuroendocrine complications...


Subject(s)
Humans , Pituitary Diseases/etiology , Craniocerebral Trauma/complications
SELECTION OF CITATIONS
SEARCH DETAIL